A sublethal dose of auranofin-induced oxidative DNA damage, followed by a strong DNA damage response activation of the DNA damage kinase Ataxia Telangiectasia and Rad3-related (ATR) in osteosarcoma and breast cancer cells. The gene discussed is ATR; the disease is breast carcinoma.